Focus on Melanoma and Skin Cancer

 

Photo by Cancer Type

FDA Approves Mekinist in Combination with Tafinlar for Advanced Melanoma

The U.S. Food and Drug Administration has approved Mekinist (trametinib) in combination with Tafinlar (dabrafenib) to treat patients with advanced melanoma that is unresectable (cannot be removed by surgery) or metastatic (late-stage).

Read More

 

Photo by Cancer Type

FDA Approves Two Drugs, Companion Diagnostic Test for Advanced Skin Cancer

The U.S. Food and Drug Administration has approved two new drugs, Tafinlar (dabrafenib) and Mekinist (trametinib), for patients with advanced (metastatic) or unresectable (cannot be removed by surgery) melanoma, the most dangerous type of skin cancer.

Read More

 

Photo by Cancer Type

Former Pro Football Coach Bill Cowher Tells Men “No Excuses” When it Comes to Getting Screened for Melanoma

A new survey shows that when it comes to getting screened for skin cancer, one in six men avoid going for fear of the results they will receive. To address this lack of action and empower men to take an active role in their skin health, former professional football coach Bill Cowher is teaming up for a second time with leading melanoma advocacy groups and Bristol-Myers Squibb Company on the educational campaign Melanoma Exposed: Screen. Protect. Know. Tell.  

Read More